Health Condition 1: C189- Malignant neoplasm of colon, unspecified Health Condition 2: C20- Malignant neoplasm of rectum
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This study is a Three Phased approach. Phase - I Prevalence of Colorectal cancer in patients attending a tertiary care Hospital. 1. All patients diagnosed with cancer and attending the OP and IP oncology department of a tertiary care hospital 2. Patients aged 18 years and above 3. Hemodynamically stable patient 4. Patient who provide Informed consent to participate in the study 5. Patients willing and able to undergo demographic assessments. Phase - II and III(A) (Nutritional Screening and Assessment, Pre-operative Colorectal cancer) 1. Patients diagnosed with colorectal cancer (CRC) with the symptoms of Diarrhea and constipation 2. Patients who Consent to participate in the nutritional screening and assessment Phase 3.Patients who can perform or undergo functional assessments such as handgrip strength, calf circumference and physical performance scales (ECOG, Karnofsky) 4.Patients who agree to follow the personalized diet chart and consume partially hydrolyzed guar gum and fermented rice as part of the intervention. 5. Patients who are willing to be observed and monitored for changes in GI symptoms during the intervention period Phase III (B) (Post Operative Colostomy) 1. Postoperative colorectal cancer patients with colostomy bag 2. Patients aged between 18 years and above 3. Individuals willing to participate in the study and provide Informed consent 4. Patients experiencing ostomy symptoms like (Diarrhea, constipation, gas production, color changes odour control, stoma blockage) 5. Participants who can adhere to the prescribed customized diet and intervention regimen.
Exclusion criteria
Exclusion criteria: This study is a Three phased approach. Phase - I Prevalence of Colorectal cancer in patients attending a tertiary care Hospital. 1. Patients without a cancer diagnosis 2. Patients under the age of 18 3. Patients unable or unwilling to complete the required assessments due to critically ill 4. Patients who do not provide Informed consent to participate in the study 5. pregnant and lactating women. Phase II and III (A)(Nutritional Screening and Assessment, Pre-operative Colorectal cancer) 1. Patients diagnosed with other types of cancer and CRC patients who do not report diarrhea and constipation 2. Patients with severe physical or cognitive impairment that precludes accurate assessment or participation 3. Pregnant and lactating women 4.Patients with dietary restrictions or allergies that prevent the consumption of guar gum or fermented rice 5. Patients who are unwilling or unable to adhere to the personalized diet plan and nutritional intervention 6. Patients with severe condition that may interfere with the intervention.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The Patients who are employed for the study under preoperative colorectal cancer will be followed up everyday till surgery with the intervention of Fermented rice and Partially hydrolyzed guar gum (PHGG). Postoperative colostomy patients will be followed up everyday for 6 weeks with the intervention of fermented rice and partially hydrolyzed guar gum during the hospital stay and once discharged the patient will be followed up through regular hospital visits/phone calls for the better management.Timepoint: Till surgery (Preoperative), 6 weeks(Postoperative) | — |
Primary
| Measure | Time frame |
|---|---|
| The Primary outcome of the study is to assess the effectiveness of the Nutritional intervention in regulating bowel movements and enhancing stool consistency (Diarrhea and Constipation) in preoperative colorectal cancer patients and to improve the gastrointestinal health like (Diarrhea, constipation, gas production, color changes, odour control and stoma blockage) in postoperative colostomy patients.Timepoint: Till surgery (Preoperative), 6 Weeks (Postoperative) | — |
Countries
India
Contacts
Tamil Nadu Government Multi Super Specialty Hospital, Chennai.